Physician profile
Amit V Patel
NPI 1346430519
$13,595.01
in general payments reported to CMS, 2019-2025
20 companies · $5,058 in 2025
The $5,058 reported for 2025 was more than what 93% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $30.66 · 2021: $3,545 · 2022: $979 · 2023: $620 · 2024: $3,167 · 2025: $5,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,000 · Travel and Lodging: $2,293 · Food and Beverage: $2,096 · Consulting Fee: $375 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,000.00 |
| Travel and Lodging | $2,293.03 |
| Food and Beverage | $2,096.12 |
| Consulting Fee | $375.00 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $12,548.30 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $302.18 | 2021-2024 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $212.03 | 2024-2025 | Lumryz |
| Actelion Pharmaceuticals US, INC. | $79.99 | 2023 | Uptravi, Opsumit |
| Janssen Biotech, INC. | $74.08 | 2023 | Simponi, Stelara, Simponi Aria |
| Resmed Corp | $51.14 | 2024 | |
| Aerin Medical INC. | $47.19 | 2025 | |
| Jazz Pharmaceuticals INC. | $31.03 | 2024 | |
| Idorsia Pharmaceuticals US INC | $30.21 | 2022-2024 | Quviviq |
| Axsome Therapeutics, INC. | $30.09 | 2023 | Sunosi |
| Noctrix Health, INC. | $29.56 | 2025 | Nidra |
| 3b Medical, INC. | $24.10 | 2024 | Luna |
| Novo Nordisk INC | $22.28 | 2021 | |
| Azurity Pharmaceuticals, INC. | $18.16 | 2024 | Horizant |
| Merck Sharp & Dohme LLC | $17.30 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $15.98 | 2021 | |
| Tactile Systems Technology INC | $15.88 | 2020 | |
| Gilead Sciences, INC. | $15.77 | 2019 | |
| Pfizer INC. | $14.96 | 2019 | |
| Genentech USA, INC. | $14.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.